 Donald Penning
Concepts (298)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Operating Rooms | 6 | 2024 | 144 | 1.590 |
Why?
| | Analgesia, Obstetrical | 9 | 2013 | 32 | 1.210 |
Why?
| | Cesarean Section | 8 | 2013 | 230 | 1.150 |
Why?
| | Anesthetics, Inhalation | 1 | 2024 | 52 | 0.790 |
Why?
| | Morphine | 3 | 2013 | 170 | 0.730 |
Why?
| | Nerve Block | 3 | 2013 | 107 | 0.720 |
Why?
| | Carbon Dioxide | 1 | 2024 | 239 | 0.720 |
Why?
| | Anesthesiology | 2 | 2024 | 178 | 0.640 |
Why?
| | Hypoxia | 6 | 2018 | 1199 | 0.590 |
Why?
| | Anesthesia, Obstetrical | 5 | 2011 | 30 | 0.590 |
Why?
| | Elective Surgical Procedures | 4 | 2019 | 202 | 0.580 |
Why?
| | Appointments and Schedules | 1 | 2019 | 96 | 0.560 |
Why?
| | Craniotomy | 1 | 2018 | 84 | 0.540 |
Why?
| | Intraoperative Complications | 2 | 2020 | 157 | 0.540 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2019 | 237 | 0.500 |
Why?
| | Obesity, Morbid | 1 | 2020 | 288 | 0.470 |
Why?
| | Analgesics, Opioid | 5 | 2013 | 1150 | 0.470 |
Why?
| | Fetal Blood | 5 | 2005 | 325 | 0.440 |
Why?
| | Glutamic Acid | 8 | 2003 | 256 | 0.390 |
Why?
| | Fetus | 6 | 2003 | 804 | 0.370 |
Why?
| | Pregnancy Complications, Cardiovascular | 2 | 2007 | 85 | 0.360 |
Why?
| | Nurse Anesthetists | 2 | 2024 | 7 | 0.360 |
Why?
| | Blood Gas Analysis | 4 | 2005 | 81 | 0.350 |
Why?
| | Pregnancy | 31 | 2013 | 7197 | 0.350 |
Why?
| | Anesthesiologists | 2 | 2024 | 68 | 0.330 |
Why?
| | Anesthesia, Epidural | 2 | 2007 | 12 | 0.320 |
Why?
| | Glutamates | 4 | 1995 | 66 | 0.310 |
Why?
| | Nasal Cavity | 2 | 2020 | 62 | 0.300 |
Why?
| | Epinephrine | 2 | 2020 | 158 | 0.300 |
Why?
| | Paranasal Sinuses | 2 | 2020 | 81 | 0.300 |
Why?
| | Delivery, Obstetric | 2 | 2007 | 161 | 0.290 |
Why?
| | Propofol | 2 | 2023 | 87 | 0.290 |
Why?
| | Magnesium Sulfate | 2 | 2000 | 18 | 0.280 |
Why?
| | Radiography, Thoracic | 1 | 2008 | 172 | 0.260 |
Why?
| | Medical Errors | 1 | 2008 | 119 | 0.260 |
Why?
| | Transposition of Great Vessels | 1 | 2007 | 42 | 0.250 |
Why?
| | Maternal-Fetal Exchange | 4 | 2000 | 170 | 0.230 |
Why?
| | Intubation, Intratracheal | 1 | 2008 | 326 | 0.230 |
Why?
| | Sheep | 13 | 2003 | 882 | 0.230 |
Why?
| | Brain Chemistry | 2 | 1999 | 117 | 0.230 |
Why?
| | Recovery Room | 2 | 2001 | 3 | 0.210 |
Why?
| | Gas Scavengers | 1 | 2024 | 4 | 0.210 |
Why?
| | Emergencies | 1 | 2005 | 175 | 0.210 |
Why?
| | Anesthesia, Inhalation | 1 | 2024 | 14 | 0.210 |
Why?
| | Analgesia, Epidural | 3 | 2000 | 39 | 0.200 |
Why?
| | Hippocampus | 4 | 1996 | 969 | 0.190 |
Why?
| | Lumbar Vertebrae | 2 | 2011 | 252 | 0.190 |
Why?
| | Feedback | 1 | 2024 | 181 | 0.190 |
Why?
| | Prospective Studies | 5 | 2024 | 8039 | 0.190 |
Why?
| | Cerebral Cortex | 4 | 1998 | 471 | 0.180 |
Why?
| | Pain Measurement | 4 | 2013 | 558 | 0.170 |
Why?
| | Bupivacaine | 4 | 2012 | 40 | 0.170 |
Why?
| | Blood Loss, Surgical | 2 | 2019 | 112 | 0.170 |
Why?
| | RNA, Long Noncoding | 1 | 2023 | 172 | 0.170 |
Why?
| | Female | 36 | 2024 | 78763 | 0.160 |
Why?
| | Fetal Diseases | 3 | 2005 | 194 | 0.160 |
Why?
| | Anesthetics, Local | 3 | 2013 | 104 | 0.160 |
Why?
| | Decision Making | 2 | 2005 | 979 | 0.160 |
Why?
| | Extracellular Vesicles | 1 | 2023 | 171 | 0.160 |
Why?
| | Hemostasis, Surgical | 1 | 2020 | 25 | 0.160 |
Why?
| | Spinal Cord Neoplasms | 1 | 2000 | 41 | 0.160 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2001 | 98 | 0.160 |
Why?
| | Paraplegia | 1 | 2000 | 60 | 0.160 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 2000 | 63 | 0.160 |
Why?
| | Anesthesia, General | 3 | 2005 | 121 | 0.160 |
Why?
| | Nasal Polyps | 1 | 2020 | 59 | 0.150 |
Why?
| | Humans | 33 | 2024 | 145491 | 0.150 |
Why?
| | Pregnancy, Animal | 1 | 2000 | 51 | 0.150 |
Why?
| | Tidal Volume | 1 | 2020 | 111 | 0.150 |
Why?
| | Paranasal Sinus Diseases | 1 | 2019 | 15 | 0.150 |
Why?
| | Glioblastoma | 1 | 2023 | 353 | 0.150 |
Why?
| | Magnesium | 1 | 2000 | 156 | 0.150 |
Why?
| | Fetal Death | 2 | 1996 | 58 | 0.150 |
Why?
| | Postoperative Care | 1 | 2001 | 286 | 0.140 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 1999 | 59 | 0.140 |
Why?
| | Glioma | 1 | 2023 | 429 | 0.140 |
Why?
| | Double-Blind Method | 3 | 2013 | 2060 | 0.140 |
Why?
| | Leukocytosis | 1 | 2018 | 32 | 0.140 |
Why?
| | Anesthesia, Spinal | 4 | 2005 | 13 | 0.140 |
Why?
| | Fetal Hypoxia | 2 | 1998 | 56 | 0.140 |
Why?
| | Time Factors | 5 | 2019 | 7171 | 0.130 |
Why?
| | Sinusitis | 1 | 2020 | 227 | 0.130 |
Why?
| | Emergency Medical Services | 1 | 2005 | 697 | 0.130 |
Why?
| | Postoperative Nausea and Vomiting | 2 | 2012 | 25 | 0.130 |
Why?
| | Adult | 20 | 2020 | 40707 | 0.130 |
Why?
| | Intracranial Hemorrhages | 1 | 2018 | 106 | 0.130 |
Why?
| | Ambulatory Surgical Procedures | 3 | 2002 | 79 | 0.130 |
Why?
| | Workload | 1 | 2019 | 168 | 0.130 |
Why?
| | Spinal Cord | 1 | 2000 | 384 | 0.130 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2018 | 127 | 0.130 |
Why?
| | Cocaine | 1 | 1999 | 161 | 0.130 |
Why?
| | Neuroblastoma | 1 | 1998 | 174 | 0.130 |
Why?
| | Tocolytic Agents | 1 | 1996 | 16 | 0.120 |
Why?
| | Pregnancy Outcome | 3 | 2007 | 497 | 0.120 |
Why?
| | Heart Rate | 1 | 2020 | 859 | 0.120 |
Why?
| | Fetal Monitoring | 2 | 2005 | 20 | 0.110 |
Why?
| | Zygote Intrafallopian Transfer | 1 | 1995 | 1 | 0.110 |
Why?
| | Embryo Transfer | 1 | 1995 | 38 | 0.110 |
Why?
| | Extracellular Space | 3 | 2003 | 119 | 0.110 |
Why?
| | Isoflurane | 1 | 1995 | 41 | 0.110 |
Why?
| | Nalbuphine | 2 | 1994 | 6 | 0.110 |
Why?
| | Pruritus | 2 | 2012 | 59 | 0.100 |
Why?
| | Infusions, Spinal | 1 | 2013 | 2 | 0.100 |
Why?
| | Brain Neoplasms | 1 | 2023 | 1329 | 0.100 |
Why?
| | Cerebrovascular Circulation | 1 | 1996 | 289 | 0.100 |
Why?
| | Abdominal Muscles | 1 | 2013 | 12 | 0.100 |
Why?
| | Hemodynamics | 5 | 2020 | 1116 | 0.100 |
Why?
| | Antithrombin III Deficiency | 1 | 1993 | 8 | 0.100 |
Why?
| | Pyramidal Tracts | 1 | 1993 | 30 | 0.100 |
Why?
| | Obstetric Labor, Premature | 1 | 1993 | 39 | 0.100 |
Why?
| | Nitrous Oxide | 1 | 1993 | 35 | 0.100 |
Why?
| | Amides | 1 | 2013 | 99 | 0.090 |
Why?
| | Brain Diseases | 1 | 1994 | 153 | 0.090 |
Why?
| | Bacteria | 1 | 2019 | 897 | 0.090 |
Why?
| | Brain | 2 | 1995 | 2944 | 0.090 |
Why?
| | Ultrasonography, Interventional | 1 | 2013 | 167 | 0.090 |
Why?
| | Cohort Studies | 2 | 2019 | 5992 | 0.090 |
Why?
| | Patient Satisfaction | 2 | 2012 | 710 | 0.090 |
Why?
| | Ilium | 1 | 2011 | 31 | 0.090 |
Why?
| | Synaptic Transmission | 1 | 1993 | 292 | 0.080 |
Why?
| | Hemorrhage | 1 | 1996 | 826 | 0.080 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 974 | 0.080 |
Why?
| | Hypoxia, Brain | 1 | 1990 | 9 | 0.080 |
Why?
| | Anesthetics, Intravenous | 2 | 2000 | 69 | 0.080 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 782 | 0.080 |
Why?
| | Administration, Intranasal | 2 | 2020 | 94 | 0.080 |
Why?
| | gamma-Aminobutyric Acid | 1 | 1991 | 194 | 0.080 |
Why?
| | Neurotransmitter Agents | 1 | 1990 | 83 | 0.080 |
Why?
| | Acidosis | 2 | 2005 | 105 | 0.070 |
Why?
| | Synapses | 1 | 1993 | 438 | 0.070 |
Why?
| | Vasoconstrictor Agents | 2 | 2020 | 150 | 0.070 |
Why?
| | Fentanyl | 2 | 2000 | 130 | 0.070 |
Why?
| | Fluoroscopy | 1 | 2008 | 181 | 0.070 |
Why?
| | Pregnancy, High-Risk | 1 | 2007 | 13 | 0.070 |
Why?
| | Age Distribution | 1 | 2008 | 403 | 0.070 |
Why?
| | Postoperative Complications | 1 | 2020 | 2962 | 0.060 |
Why?
| | Young Adult | 3 | 2013 | 14192 | 0.060 |
Why?
| | Animals | 15 | 2003 | 38141 | 0.060 |
Why?
| | Lung | 1 | 2020 | 4103 | 0.060 |
Why?
| | Attitude to Health | 1 | 1990 | 431 | 0.060 |
Why?
| | Trachea | 1 | 2008 | 258 | 0.060 |
Why?
| | Delivery Rooms | 1 | 2006 | 10 | 0.060 |
Why?
| | Uterus | 2 | 1999 | 225 | 0.060 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2000 | 563 | 0.060 |
Why?
| | Amino Acids | 1 | 1990 | 521 | 0.060 |
Why?
| | Labor, Obstetric | 1 | 2006 | 68 | 0.060 |
Why?
| | Medical Staff, Hospital | 1 | 2006 | 80 | 0.060 |
Why?
| | Fetal Alcohol Spectrum Disorders | 2 | 1997 | 76 | 0.060 |
Why?
| | Operating Room Nursing | 2 | 2002 | 7 | 0.060 |
Why?
| | Social Perception | 1 | 2006 | 107 | 0.050 |
Why?
| | Physician-Patient Relations | 1 | 1990 | 590 | 0.050 |
Why?
| | Blood Pressure | 3 | 2020 | 1782 | 0.050 |
Why?
| | Ethanol | 3 | 1997 | 632 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2019 | 2030 | 0.050 |
Why?
| | Gestational Age | 4 | 1997 | 988 | 0.050 |
Why?
| | Cooperative Behavior | 1 | 2006 | 464 | 0.050 |
Why?
| | Telencephalon | 1 | 2003 | 16 | 0.050 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2002 | 16 | 0.050 |
Why?
| | Adolescent | 4 | 2008 | 22485 | 0.050 |
Why?
| | Asphyxia Neonatorum | 1 | 2002 | 21 | 0.050 |
Why?
| | Umbilical Cord | 1 | 2003 | 92 | 0.050 |
Why?
| | Programming, Linear | 1 | 2002 | 1 | 0.050 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2023 | 153 | 0.050 |
Why?
| | Oxygen | 2 | 1999 | 986 | 0.050 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2002 | 80 | 0.040 |
Why?
| | Microdialysis | 3 | 1998 | 56 | 0.040 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2002 | 49 | 0.040 |
Why?
| | Postanesthesia Nursing | 1 | 2001 | 2 | 0.040 |
Why?
| | Male | 7 | 2020 | 72817 | 0.040 |
Why?
| | Neuroprotective Agents | 1 | 2002 | 147 | 0.040 |
Why?
| | Pre-Eclampsia | 2 | 2000 | 206 | 0.040 |
Why?
| | Progesterone | 1 | 2002 | 209 | 0.040 |
Why?
| | Hospital Costs | 1 | 2002 | 125 | 0.040 |
Why?
| | Monte Carlo Method | 1 | 2001 | 153 | 0.040 |
Why?
| | Meperidine | 1 | 2000 | 6 | 0.040 |
Why?
| | Drug Administration Routes | 1 | 2020 | 42 | 0.040 |
Why?
| | Microglia | 1 | 2023 | 275 | 0.040 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2020 | 35 | 0.040 |
Why?
| | Infant, Newborn | 3 | 2008 | 6437 | 0.040 |
Why?
| | Administration, Topical | 1 | 2019 | 153 | 0.040 |
Why?
| | Neoplastic Stem Cells | 1 | 2023 | 409 | 0.040 |
Why?
| | Hemostatic Techniques | 1 | 2019 | 53 | 0.040 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2000 | 97 | 0.040 |
Why?
| | Cell Survival | 1 | 2002 | 1094 | 0.040 |
Why?
| | Heart Rate, Fetal | 1 | 1999 | 31 | 0.040 |
Why?
| | Infusions, Intravenous | 1 | 2000 | 427 | 0.040 |
Why?
| | Piperidines | 1 | 2000 | 221 | 0.040 |
Why?
| | Procaine | 1 | 1998 | 10 | 0.040 |
Why?
| | Information Systems | 1 | 1998 | 56 | 0.040 |
Why?
| | Spinal Puncture | 1 | 1998 | 18 | 0.040 |
Why?
| | Anesthesia | 1 | 2002 | 258 | 0.030 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 195 | 0.030 |
Why?
| | Length of Stay | 2 | 2002 | 1348 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2008 | 17269 | 0.030 |
Why?
| | Malpractice | 1 | 1998 | 45 | 0.030 |
Why?
| | Lidocaine | 1 | 1998 | 55 | 0.030 |
Why?
| | Nitrites | 1 | 1998 | 89 | 0.030 |
Why?
| | Prostaglandins E | 1 | 1997 | 33 | 0.030 |
Why?
| | Nitrates | 1 | 1998 | 100 | 0.030 |
Why?
| | Caregivers | 1 | 2006 | 1070 | 0.030 |
Why?
| | Patient Care Planning | 1 | 1998 | 170 | 0.030 |
Why?
| | Flumazenil | 1 | 1996 | 8 | 0.030 |
Why?
| | Endoscopy | 1 | 2019 | 317 | 0.030 |
Why?
| | Hepatic Encephalopathy | 1 | 1996 | 25 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 1999 | 515 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 1998 | 288 | 0.030 |
Why?
| | Computer Simulation | 1 | 2001 | 1026 | 0.030 |
Why?
| | Scoliosis | 1 | 1998 | 224 | 0.030 |
Why?
| | Software | 1 | 2001 | 698 | 0.030 |
Why?
| | Neurons | 2 | 2002 | 1647 | 0.030 |
Why?
| | Embryo Implantation | 1 | 1995 | 30 | 0.030 |
Why?
| | Hospitals | 1 | 2019 | 732 | 0.030 |
Why?
| | Labor Stage, First | 1 | 1994 | 5 | 0.030 |
Why?
| | Nausea | 1 | 1995 | 113 | 0.030 |
Why?
| | Patient Discharge | 1 | 2001 | 992 | 0.030 |
Why?
| | Fertilization in Vitro | 1 | 1995 | 93 | 0.030 |
Why?
| | Infant | 1 | 2008 | 10064 | 0.030 |
Why?
| | Apoptosis | 1 | 2002 | 2411 | 0.030 |
Why?
| | Guinea Pigs | 1 | 1993 | 160 | 0.020 |
Why?
| | Child, Preschool | 1 | 2008 | 11837 | 0.020 |
Why?
| | Necrosis | 1 | 1994 | 244 | 0.020 |
Why?
| | Nitric Oxide | 1 | 1998 | 894 | 0.020 |
Why?
| | Pregnancy Complications | 1 | 1999 | 612 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 1993 | 199 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 1993 | 248 | 0.020 |
Why?
| | Evoked Potentials | 1 | 1993 | 131 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 1993 | 571 | 0.020 |
Why?
| | Chronic Disease | 1 | 1998 | 1816 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 1993 | 1047 | 0.020 |
Why?
| | Palpation | 1 | 2011 | 15 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1993 | 581 | 0.020 |
Why?
| | Florida | 1 | 2011 | 118 | 0.020 |
Why?
| | Potassium | 1 | 1991 | 153 | 0.020 |
Why?
| | Heart Defects, Congenital | 1 | 1999 | 909 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4323 | 0.020 |
Why?
| | Patient Positioning | 1 | 2011 | 69 | 0.020 |
Why?
| | Child | 2 | 2008 | 22680 | 0.020 |
Why?
| | Culture Techniques | 1 | 1990 | 66 | 0.020 |
Why?
| | Observer Variation | 1 | 2011 | 358 | 0.020 |
Why?
| | Costs and Cost Analysis | 2 | 2002 | 221 | 0.020 |
Why?
| | Aspartic Acid | 1 | 1990 | 87 | 0.020 |
Why?
| | Kinetics | 1 | 1993 | 1605 | 0.020 |
Why?
| | Glycine | 1 | 1990 | 186 | 0.020 |
Why?
| | Linear Models | 1 | 2011 | 848 | 0.020 |
Why?
| | Middle Aged | 4 | 2019 | 36176 | 0.020 |
Why?
| | Alcohol Drinking | 1 | 1995 | 837 | 0.020 |
Why?
| | Ultrasonography | 1 | 2011 | 784 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 2129 | 0.010 |
Why?
| | Calcium | 1 | 1991 | 1190 | 0.010 |
Why?
| | United States | 2 | 2019 | 16115 | 0.010 |
Why?
| | Organizational Culture | 1 | 2006 | 161 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2019 | 11831 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3424 | 0.010 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2003 | 47 | 0.010 |
Why?
| | Neurotoxins | 1 | 2002 | 28 | 0.010 |
Why?
| | Dizocilpine Maleate | 1 | 2002 | 24 | 0.010 |
Why?
| | Carbocyanines | 1 | 2002 | 37 | 0.010 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2002 | 42 | 0.010 |
Why?
| | N-Methylaspartate | 1 | 2002 | 43 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 2002 | 120 | 0.010 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2002 | 113 | 0.010 |
Why?
| | Anxiety | 1 | 1990 | 1127 | 0.010 |
Why?
| | Accounting | 1 | 2002 | 2 | 0.010 |
Why?
| | Planning Techniques | 1 | 2002 | 15 | 0.010 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2002 | 107 | 0.010 |
Why?
| | Pregnanolone | 1 | 2002 | 34 | 0.010 |
Why?
| | Psychometrics | 1 | 2006 | 731 | 0.010 |
Why?
| | Cell Count | 1 | 2002 | 320 | 0.010 |
Why?
| | Health Care Rationing | 1 | 2002 | 56 | 0.010 |
Why?
| | Membrane Potentials | 1 | 2002 | 278 | 0.010 |
Why?
| | Benzimidazoles | 1 | 2002 | 187 | 0.010 |
Why?
| | Canada | 1 | 2002 | 434 | 0.010 |
Why?
| | Subarachnoid Space | 1 | 2000 | 8 | 0.010 |
Why?
| | Apgar Score | 1 | 2000 | 21 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2002 | 883 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 2002 | 335 | 0.010 |
Why?
| | Anesthesia Department, Hospital | 1 | 2000 | 5 | 0.010 |
Why?
| | Time and Motion Studies | 1 | 2000 | 28 | 0.010 |
Why?
| | North Carolina | 1 | 2000 | 130 | 0.010 |
Why?
| | Salaries and Fringe Benefits | 1 | 2000 | 57 | 0.010 |
Why?
| | Efficiency | 1 | 2000 | 104 | 0.010 |
Why?
| | Eclampsia | 1 | 1998 | 6 | 0.010 |
Why?
| | Monitoring, Intraoperative | 1 | 1999 | 67 | 0.010 |
Why?
| | Anions | 1 | 1998 | 31 | 0.010 |
Why?
| | Attitude of Health Personnel | 1 | 2006 | 1188 | 0.010 |
Why?
| | Thioacetamide | 1 | 1996 | 2 | 0.010 |
Why?
| | Reference Values | 1 | 1998 | 797 | 0.010 |
Why?
| | Aged | 2 | 2002 | 26125 | 0.010 |
Why?
| | Abnormalities, Drug-Induced | 1 | 1996 | 38 | 0.010 |
Why?
| | Medicaid | 1 | 2000 | 466 | 0.010 |
Why?
| | Risk Factors | 1 | 1990 | 10874 | 0.010 |
Why?
| | Mitochondria | 1 | 2002 | 990 | 0.010 |
Why?
| | Arteries | 1 | 1996 | 261 | 0.010 |
Why?
| | Parity | 1 | 1994 | 109 | 0.010 |
Why?
| | Algorithms | 1 | 2002 | 1855 | 0.010 |
Why?
| | Oxytocin | 1 | 1994 | 51 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1996 | 2526 | 0.010 |
Why?
| | Rats | 1 | 1996 | 5581 | 0.000 |
Why?
|
|
Penning's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|